Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Mangafodipir trisodium
Drug ID BADD_D01348
Description Mangafodipir is a contrast agent used as a diagnostic tool administered intravenously to enhance contrast in magnetic resonance imaging (MRI) of the liver and pancreas. This drug is made up of paramagnetic manganese (II) ions combined with the chelating agent _fodipir_ (dipyridoxyl diphosphate, DPDP). Manganese absorption into the tissues that makes the normal tissue appear brighter in MRI is limited in abnormal or cancerous tissue. Enhanced contrast by mangafodipir improves visualization and detection of lesions of the liver formed from metastatic disease or hepatocellular carcinomas. The contrast agent is present as mangafodipir trisodium marketed under the name Teslascan. Teslascan has been removed from the Drug Product List by FDA in 2003, and withdrawn from the European market in 2012.
Indications and Usage Indicated for use as an organ-specific paramagnetic contrast agent developed for imaging of the hepatobiliary system and detecting lesions in liver and pancreas.
Marketing Status approved; investigational; withdrawn
ATC Code V08CA05
DrugBank ID DB06796
KEGG ID D04848
MeSH ID C060076
PubChem ID 160036
TTD Drug ID D04BKZ
NDC Product Code 65392-2204
UNII 129FW80TG4
Synonyms N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid | DPDP | mangafodipir | manganese-DPDP | Mn-DPDP | manganese dipyridoxyl diphosphate | Teslascan | calmangafodipir | Ca4Mn(DPDP)5 | mangafodipir trisodium | mangafodipir trisodium, anhydrous
Chemical Information
Molecular Formula C22H27MnN4Na3O14P2
CAS Registry Number 140678-14-4
SMILES [H+].[H+].[H+].CC1=NC=C(C(=C1[O-])CN(CCN(CC2=C(C(=NC=C2COP(=O)([O-])[O-])C)[O-]) CC(=O)[O-])CC(=O)[O-])COP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Mn+2]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Chest pain22.12.02.003; 08.01.08.002; 02.02.02.011--Not Available
Dermatitis23.03.04.002--Not Available
Discomfort08.01.08.003--Not Available
Dizziness17.02.05.003; 02.11.04.006; 24.06.02.007--
Dysgeusia17.02.07.003; 07.14.03.001--
Flushing24.03.01.002; 23.06.05.003; 08.01.03.025--
Gastrointestinal pain07.01.05.005--
Haemoglobin13.01.05.018--Not Available
Headache17.14.01.001--
Hypersensitivity10.01.03.003--
Hypertension24.08.02.001--
Menopausal symptoms21.02.02.002--Not Available
Nausea07.01.07.001--
Pain08.01.08.004--
Palpitations02.11.04.012--
Pneumonia22.07.01.003; 11.01.09.003--Not Available
Pruritus23.03.12.001--
Rash23.03.13.001--Not Available
Sepsis11.01.11.003--
Urticaria23.04.02.001; 10.01.06.001--
Vomiting07.01.07.003--
Injection site discomfort12.07.03.019; 08.02.03.018--Not Available
Haemorrhage24.07.01.002--Not Available
Hot flush08.01.03.027; 24.03.01.005; 21.02.02.001--
Hepatic cancer16.07.02.004; 09.04.02.008--Not Available
Hepatocellular carcinoma16.07.02.005; 09.04.02.010--Not Available
The 1th Page    1    Total 1 Pages